Polyclonal antibody for specifically recognizing AAV9 capsid protein and preparation method thereof
A polyclonal antibody, capsid protein technology, applied in the field of medicine and biochemical industry, can solve the problem of lack of specificity of antibodies
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] AAV capsid variable region protein sequence was obtained
[0027] The amino acid sequence of AAV1-AAV10 capsid protein was downloaded from the NCBI website, imported into the software DNAMAN, sequence homology alignment analysis, and found 8 AAV9 variable regions (Aa262-269, Aa448-483, Aa488-510, Aa527- 540, Aa545-557, Aa576-601, Aa661-668, Aa706-718), splicing the variable region sequence, the obtained sequence is the AAV9 capsid protein variable region sequence, and the DNA sequence encoding the variable region is composed of gold. The pET-30a prokaryotic expression vector was synthesized and constructed by Weizhi Biotechnology Co., Ltd. The 5'-end restriction site was XhoI, and the 3'-end restriction site was NdeI. The AAV9 variable region plasmid pET30a-AAV9-VR was digested with XhoI+NdeI and separated by 1% agarose gel electrophoresis. Two restriction fragments of 5500bp and 1000bp were found (Figure 1). The results were consistent with expectations. The recombina...
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com